Clinical Trials

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

320 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04797806 2021-03-15

SAINT

206 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

60 enrolled

Adenocarcinoma of Lung

NCT04058704 2019-08-15

SMART

296 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

70 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Phase NA Unknown

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02726568 2019-02-19

High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Phase NA Unknown

66 enrolled

Non-Small-Cell Lung

NCT03754530 2018-11-27

Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation

162 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03749213 2018-11-21

Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer

36 enrolled

EGF-R Positive Non-Small Cell Lung Cancer

NCT03349203 2018-07-18

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

60 enrolled

EGF-R Positive Non-Small Cell Lung Cancer

NCT03396185 2018-07-18

Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02125240 2018-07-16

ICWIP

124 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

118 enrolled

Lung Neoplasms

NCT03346811 2017-11-17

CHALLENGE

120 enrolled

Plasma EGFR Mutation-positive Lung Cancer

NCT02404675 2017-07-28

INCREASE

240 enrolled

NSCLC

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Drug-Related Side Effects and Adverse Reactions

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02960607 2016-11-18

High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02961270 2016-11-11

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

330 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

67 enrolled

NSCLC

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

130 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01646450 2015-09-09

First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01707329 2015-09-09

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

180 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01926171 2015-07-15

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02062515 2015-07-15

Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency

Carcinoma, Non-Small-Cell Lung

NCT02027090 2015-05-22

High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease

64 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02278458 2015-05-22

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Phase 1 Unknown

24 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

192 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Phase 1 Unknown

9 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02009605 2015-03-05

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

Squamous Cell Carcinoma of Lung

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

10 enrolled

Tumor-Agnostic

Neoplasms, Second Primary

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

100 enrolled

NSCLC

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

20 enrolled